PORTAGE BIOTECH INC.

EDGAR

Market value is not computed: this company’s US price is per depositary share, not per ordinary share.

Annual consolidated revenue for 2026: about USD 97K, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
12 transactions, 71,704 shares
Sum of shares × price per share: 314,634.7606
Open-market sales (code S)
1 transactions, 393 shares
Sum of shares × price per share: 1,630.95

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-10-07 Villani Fiorenzo P 5,150 3.80
  • 2026-09-22 Villani Fiorenzo P 10,000 4.4047
  • 2026-09-16 Villani Fiorenzo P 4,265 4.05
  • 2026-09-15 Villani Fiorenzo P 10,382 4.0708
  • 2026-09-15 Villani Fiorenzo P 7,900 4.1533

5% holders (Schedule 13D and 13G)

  • JANE STREET GROUP, LLC 1.3% SCHEDULE 13G/A 09/30/2026
  • Jane Street Capital, LLC 0.0% SCHEDULE 13G/A 09/30/2026
  • Jane Street Global Trading, LLC 1.3% SCHEDULE 13G/A 09/30/2026

Institutional holders (Form 13F)

  • JANE STREET GROUP, LLC 20,186 SH
  • GSA CAPITAL PARTNERS LLP 18,324 SH
  • Cambridge Investment Research Advisors, Inc. 16,765 SH
  • HRT FINANCIAL LP 14,221 SH
  • QTR Family Wealth, LLC 13,345 SH

Trades by members of Congress

See all insider transactions

Latest fiscal year

Revenue

97 thousand USD

2026 · USD

Exact inputs and evidence

Operating margin

-23,810.31%

2026 · %

Exact inputs and evidence
  • Operating Income: -23096000 USD Source
  • Revenue: 97000 USD Source

Operating cash flow

-20.5 million USD

2026 · USD

Exact inputs and evidence
  • Operating Cash Flow: -20548000 USD Source

Free cash flow

-21.6 million USD

2026 · USD

Exact inputs and evidence
  • Operating Cash Flow: -20548000 USD Source
  • Capital Expenditure: 1040000 USD Source
Cash and cash equivalents
486 thousand USD Source
Exact value

486000 USD

Long-term debt including current maturities
Not available
Shares outstanding
281 million shares Source
Exact value

280720000 shares

Reported share-count change

7.68% · 20 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 260689000 shares · 2017-03-31· Source
  • 280720000 shares · 2018-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-67.3 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Net income: -39373000 USD · 2023-10-01 – 2023-12-31 Source
  • Net income: -75339000 USD · 2023-04-01 – 2024-03-31 Source
  • Net income: -50450000 USD · 2023-04-01 – 2023-12-31 Source
  • Net income: -1656000 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: -1360000 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-9.8 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Operating cash flow: -11176000 USD · 2023-04-01 – 2023-12-31 Source
  • Operating cash flow: -7745000 USD · 2023-04-01 – 2023-09-30 Source
  • Operating cash flow: -14297000 USD · 2023-04-01 – 2024-03-31 Source
  • Operating cash flow: -11176000 USD · 2023-04-01 – 2023-12-31 Source
  • Operating cash flow: -1686000 USD · 2024-04-01 – 2024-06-30 Source
  • Operating cash flow: -3246000 USD · 2024-04-01 – 2024-09-30 Source
  • Operating cash flow: -1686000 USD · 2024-04-01 – 2024-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2026-03-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2026-03-31
  • Operating income: 10 of 11 periods available· newest 2026-03-31
  • Net income: 11 of 11 periods available· newest 2026-03-31
  • Operating cash flow: 11 of 11 periods available· newest 2026-03-31
  • Capital expenditure: 2 of 11 periods available· newest 2026-03-31
  • Total assets: 1 of 11 periods available· newest 2026-03-31
  • Total liabilities: 1 of 11 periods available· newest 2026-03-31
  • Current assets: 1 of 11 periods available· newest 2026-03-31
  • Current liabilities: 1 of 11 periods available· newest 2026-03-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2026-03-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 31.86 million

    Prior period

    −USD 6.77 million

    –

    Current period

    −USD 38.63 million

    –

    Exact inputs and evidence

    -38626000 − -6767000 = -31859000 USD

    -6767000 USD · 2024-04-01 – 2025-03-31

    Inspect prior input Prior source

    -38626000 USD · 2025-04-01 – 2026-03-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 15.09 million

    Prior period

    −USD 5.46 million

    –

    Current period

    −USD 20.55 million

    –

    Exact inputs and evidence

    -20548000 − -5462000 = -15086000 USD

    -5462000 USD · 2024-04-01 – 2025-03-31

    Inspect prior input Prior source

    -20548000 USD · 2025-04-01 – 2026-03-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-04-01 – 2026-03-31

  • Revenue USD 97,000 100% of revenue
  • Operating costs Derived USD 23.19 million 23,910% of revenue
  • Operating income −USD 23.1 million −23,810% of revenue
  • Tax, interest and other Derived USD 15.53 million 16,010% of revenue
  • Net income −USD 38.63 million −39,821% of revenue

Cash

  • Operating cash flow −USD 20.55 million −21,184% of revenue
  • Capital expenditure USD 1.04 million 1,072% of revenue
  • Free cash flow Derived −USD 21.59 million −22,256% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2026 Operating loss: operating costs were 23,910% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2026 2025-04-01 – 2026-03-3197000 23193000 Derived -23096000 15530000 Derived -38626000 -21588000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 97K 2026
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.104.8K78.6K52.4K26.2K0.02026
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2026Revenue97000

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2026Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -23,810.3% 2026
Net margin -39,820.6% 2026
Free cash flow margin -22,255.7% 2026
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3,186%-8,362%-19,910%-31,458%-43,006%2026
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2026Operating margin-23,810.3%
2026Net margin-39,820.6%
2026Free cash flow margin-22,255.7%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -20.5M 2026
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.6M-4.3M-10.3M-16.2M-22.2M2026
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2026Operating cash flow-20548000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -21.6M 2026
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.7M-4.5M-10.8M-17.1M-23.3M2026
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2026Free cash flow-21588000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

66.6% 2026
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.72%54%36%18%0%2026
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2026Liabilities / assets66.6%

Current assets to current liabilities

Current assets divided by current liabilities.

0.31× 2026
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.34×0.25×0.17×0.08×0.00×2026
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2026Current assets / current liabilities0.31×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2017 2016-04-01 – 2017-03-31
USD 16.3 million
Exact value

Exact value: 16299000 USD

2016-04-01 – 2017-03-31: 16299000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.32 million
Exact value

Exact value: -1321000 USD

2016-04-01 – 2017-03-31: -1321000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2017-04-01 – 2018-03-31
USD 123.74 million
Exact value

Exact value: 123741000 USD

2017-04-01 – 2018-03-31: 123741000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.07 million
Exact value

Exact value: -1073000 USD

2017-04-01 – 2018-03-31: -1073000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2019 2018-04-01 – 2019-03-31
−USD 2.64 million
Exact value

Exact value: -2635000 USD

2018-04-01 – 2019-03-31: -2635000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 858,000
Exact value

Exact value: -858000 USD

2018-04-01 – 2019-03-31: -858000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2019-04-01 – 2020-03-31
−USD 5.33 million
Exact value

Exact value: -5333000 USD

2019-04-01 – 2020-03-31: -5333000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.71 million
Exact value

Exact value: -3714000 USD

2019-04-01 – 2020-03-31: -3714000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2020-04-01 – 2021-03-31
−USD 15.83 million
Exact value

Exact value: -15833000 USD

2020-04-01 – 2021-03-31: -15833000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.28 million
Exact value

Exact value: -4284000 USD

2020-04-01 – 2021-03-31: -4284000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2021-04-01 – 2022-03-31
−USD 16.87 million
Exact value

Exact value: -16870000 USD

2021-04-01 – 2022-03-31: -16870000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.76 million
Exact value

Exact value: -6764000 USD

2021-04-01 – 2022-03-31: -6764000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2022-04-01 – 2023-03-31
−USD 104.61 million
Exact value

Exact value: -104611000 USD

2022-04-01 – 2023-03-31: -104611000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.07 million
Exact value

Exact value: -12073000 USD

2022-04-01 – 2023-03-31: -12073000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3,000
Exact value

Exact value: 3000 USD

2022-04-01 – 2023-03-31: 3000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.08 million
Calculation and evidence

-12073000 − 3000 USD

Exact free cash flow: -12076000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2023-04-01 – 2024-03-31
−USD 75.34 million
Exact value

Exact value: -75339000 USD

2023-04-01 – 2024-03-31: -75339000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 14.3 million
Exact value

Exact value: -14297000 USD

2023-04-01 – 2024-03-31: -14297000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2024-04-01 – 2025-03-31
−USD 6.77 million
Exact value

Exact value: -6767000 USD

2024-04-01 – 2025-03-31: -6767000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.46 million
Exact value

Exact value: -5462000 USD

2024-04-01 – 2025-03-31: -5462000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2026 2025-04-01 – 2026-03-31
−USD 38.63 million
Exact value

Exact value: -38626000 USD

2025-04-01 – 2026-03-31: -38626000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 20.55 million
Exact value

Exact value: -20548000 USD

2025-04-01 – 2026-03-31: -20548000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.04 million
Exact value

Exact value: 1040000 USD

2025-04-01 – 2026-03-31: 1040000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.59 million
Calculation and evidence

-20548000 − 1040000 USD

Exact free cash flow: -21588000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

341 filings · 1,258 latest values · 1,258 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001095435, 1095435, ALP, PRTG, edgar:1095435, ptgef

Also known as Alpha Compute Corp, AlphaTON Capital Corp, BONTAN CORP INC, DEALCHECK COM INC, PORTAGE BIOTECH INC., Portage Biotech Inc., Portage Biotech Inc, Portage Biotech Inc.